Selected References
- Barr M Jr, Cohen MM Jr. 1991. ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology 44:485-95.
- Bhatt-Mehta V, Deluga KS. 1993. Fetal exposure to lisinopril: neonatal manifestations and management. Pharmacotherapy 13(5): 515-518.
- Cooper WO, et al. 2006. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354(23): 2443-2451.
- Filler G, et al. 2003. Early dialysis in a neonate with intrauterine lisinopril exposure. Arch Dis Child Fetal Neonatal Ed 88(2): F154-156.
- Friedman JM. 2006. ACE inhibitors and congenital anomalies. N Engl J Med 354: 2498-2500.
- Merck Sharp and Dohme Corp. 2018. Prinivil product label.
- National Collaborating Centre for Women’s and Children’s Health (UK). 2011. Hypertension in Pregnancy. Appendix O. Safety of commonly used antihypertensive drugs during breastfeeding. NICE Clinical Guidelines, No. 107. London: RCOG Press.
- Pryde PG, et al. 1993. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3:1575-1582.
- Rosa F, Bosco L. 1991. Infant renal failure with maternal ACE inhibition. Am J Obstet Gynecol 161(1 Part 2):273 (abstract).
- Tomlinson AJ, et al. 2000. Malignant primary hypertension in pregnancy treated with lisinopril. Ann Pharmacother 34(2): 180-182.
- S. Food and Drug Administration. (FDA) 1992. Upgraded warning on the use of ACE inhibitors during pregnancy.
- Yip SK, et al.1998. Exposure to angiotensin-converting enzyme inhibitors during first trimester: is it safe to fetus? Acta Obstet Gynecol Scand 77:570-571.
